| CPC C12N 5/0619 (2013.01) [A61K 35/30 (2013.01); C12N 5/0012 (2013.01); C12N 2501/39 (2013.01); C12N 2501/42 (2013.01); C12N 2506/45 (2013.01)] | 30 Claims |
|
1. A neural tissue unit for use in cell therapy, wherein the neural tissue unit is implantable in the nervous system of a human or non-human mammal, wherein said neural tissue unit contains differentiated post-mitotic neuronal cells, having a phenotype of interest corresponding to the phenotype of defective cells to be replaced, and glial cells, said post-mitotic neuronal cells and glial cells being organized in a three-dimensional array in an extracellular matrix, said unit being obtained from a cellular microcompartment comprising a hydrogel capsule surrounding a single neural tissue unit, said differentiated post-mitotic neuronal cells having been obtained from mammalian pluripotent stem cells differentiated into post-mitotic neuronal cells within said hydrogel capsule and said hydrogel capsule being at least partially removed prior to use of said neural tissue unit.
|